Dermal Fillers Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has conducted an extensive analysis of the Dermal Fillers Market, delivering a thorough report on its global landscape. The report provides crucial insights into market dynamics, trends, opportunities, and challenges, offering a comprehensive overview of the market structure. With exclusive data and statistics, the research publication forecasts the expected growth path of the Dermal Fillers Market spanning from 2023 to 2030.

The worldwide dermal fillers market is anticipated to grow at a compound annual growth rate (CAGR) of 9.6%, resulting in an escalation from US$5.5 billion in 2023 to US$10.5 billion by the conclusion of 2030.

Key Insights:

Dermal Fillers Market Size (2023E): US$5.5 Bn

Projected Market Value (2030F): US$10.5 Bn

Global Market Growth Rate (CAGR 2023 to 2030): 9.6%

Historical Market Growth Rate (CAGR 2018 to 2022): 8.5%

Dermal Fillers Market - Report Scope

In the realm of cosmetic dermatology, dermal fillers serve as injectable substances designed to increase volume in specific areas of the skin, reducing the appearance of wrinkles, fine lines, and sagging. Typically composed of hyaluronic acid, collagen, or synthetic compounds, dermal fillers aim to restore a youthful fullness to the skin. Due to their effectiveness in addressing signs of aging, this non-invasive cosmetic procedure has gained popularity, offering individuals a temporary solution to achieve a rejuvenated appearance without the downtime associated with surgical interventions.

Numerous factors significantly contribute to the global dermal fillers market. The growing aesthetic consciousness and preference for minimally invasive treatments among consumers have driven the demand for dermal fillers. Furthermore, advancements in product formulations that promise natural-looking and long-lasting results fuel market expansion. The increasing aging population worldwide, particularly in developed economies, is another driving force as individuals seek anti-aging solutions. Additionally, the proliferation of beauty-enhancing treatments globally and the growing acceptance of such procedures further propel the dermal fillers market toward sustained growth.

Market Growth Drivers

The global dermal fillers market is driven by the rising prevalence of aesthetic awareness among consumers, which is closely linked to evolving societal standards and an increased focus on personal well-being. With a broader definition of beauty becoming prevalent, individuals are empowered to choose products and procedures that align with their aesthetic preferences. This has led to a notable surge in demand for cosmetic treatments like dermal fillers, as people seek to enhance their physical appearance to meet their beauty ideals.

Various factors contribute to the growth of aesthetic consciousness. Social media and digital communication have played a significant role, exposing individuals to diverse beauty standards and influencing their perception of aesthetics. As people aspire for a youthful and rejuvenated look, they explore cosmetic interventions like dermal fillers. Moreover, the normalization of such procedures by influencers and celebrities has fostered wider societal acceptance of aesthetic enhancements.

Market Restraints

Despite the significant growth of the global dermal fillers market, a major challenge lies in the regulatory framework governing cosmetic procedures. Stringent regulations and diverse approval processes across regions create obstacles for market participants. Regulatory bodies rigorously examine dermal fillers to ensure their safety and effectiveness before granting commercial authorization.

These prolonged and complex approval procedures can hinder the timely introduction of new products, stifling innovation and limiting consumer choice. Moreover, regulatory changes introduce uncertainty for manufacturers and healthcare practitioners, impacting the promotion and application of dermal fillers. Another challenge is the intensifying competition among manufacturers, leading to pricing pressure. With more companies entering the aesthetic procedures market, there's a proliferation of dermal filler products. This heightened competition forces manufacturers to adopt pricing strategies that may affect long-term profitability. Despite the importance of innovation, the abundance of product options complicates consumer decision-making and reduces the market's overall value.

Opportunities

The increasing prevalence of the geriatric population presents a significant opportunity for the global dermal fillers market. As more individuals enter their middle and later years, there's a growing demand for effective solutions to combat the visible signs of aging. This demographic trend is particularly prominent in developed nations, where advancements in healthcare have extended life expectancy.

The aging population actively seeks non-invasive cosmetic treatments to address age-related concerns such as volume loss and wrinkles. Dermal fillers offer an appealing solution, aligning with the preferences of this demographic for effective yet minimally invasive procedures. With natural collagen and hyaluronic acid levels diminishing with age, dermal fillers provide a means to restore volume and refine facial contours without the need for surgery. This presents a favorable market environment for healthcare professionals and dermal filler manufacturers to cater to the needs of this demographic.

Key Questions Answered in Report::

What is the projected growth rate of the global dermal fillers market?
What factors are driving the growth of the dermal fillers market?
What are the regulatory challenges faced by participants in the dermal fillers market?
How does the increasing geriatric population contribute to market opportunities for dermal fillers?
What are the regional trends and market dynamics affecting the dermal fillers industry?
How does competition among manufacturer's impact pricing and product innovation in the dermal fillers market?

Competitive Intelligence and Business Strategy

To maintain and expand their market share, leading dermal filler companies employ diverse strategies, navigating a competitive landscape shaped by consumer preferences, regulations, and innovation. They prioritize research and development, investing heavily to develop innovative formulations that offer improved durability, natural results, and reduced side effects.

These market leaders differentiate themselves by embracing technological advancements, appealing to both healthcare professionals and consumers seeking cutting-edge solutions. They also pursue geographic expansion, strategically targeting regions with high demand for aesthetic procedures, while adapting their marketing and regulatory approaches to local nuances to build brand awareness and consumer trust. Building strong relationships with healthcare professionals is another key strategy. By providing comprehensive training, educational materials, and support, they cultivate a network of skilled advocates who endorse their products, influencing their peers and attracting loyal customers.

Key Companies Profiled
Galderma Pharma S.A
Sinclair Pharma plc
Zimmer Biomet Holdings
Allergan plc.
Anika Therapeutics Inc.
Merz Pharma GmbH & Co. KGaA
Suneva Medical Inc.
Teoxane Laboratories Inc.

Prollenium Medical Technologies Inc.

Laboratoires Vivacy SAS
Fidia Pharma USA Inc.

Dermal Fillers Market Segmentation

By Product:
Absorbable
Non-Absorbable
By Ingredient:
Hyaluronic Acid
Poly-L-Lactic Acid
Calcium Hydroxylapatite
Polymethyl methacrylate
Collagen
By Application:
Aesthetic Restoration
Dentistry
Reconstructive Surgery
By Distribution Channel:

Retail Pharmacies and Drug Stores

Clinics and Hospital Pharmacies

Online Pharmacies
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33696

1. Executive Summary

1.1. Global Dermal Fillers Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Dermal Fillers Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Dermal Fillers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Dermal Fillers Market Outlook: Product
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  - 3.3.3.1. Absorbable
  - 3.3.3.2. Non-Absorbable
3.4. Market Attractiveness Analysis: Product
3.5. Global Dermal Fillers Market Outlook: Ingredient
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Ingredient, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
  - 3.5.3.1. Hyaluronic Acid
  - 3.5.3.2. Poly-L-Lactic Acid
  - 3.5.3.3. Calcium Hydroxylapatite
  - 3.5.3.4. Polymethyl methacrylate
  - 3.5.3.5. Collagen
3.6. Market Attractiveness Analysis: Ingredient
3.7. Global Dermal Fillers Market Outlook: Application
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.7.3.1. Aesthetic Restoration
  - 3.7.3.2. Dentistry
  - 3.7.3.3. Reconstructive Surgery
3.8. Market Attractiveness Analysis: Application
3.9. Global Dermal Fillers Market Outlook: Distribution Channel
- 3.9.1. Introduction / Key Findings
- 3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
- 3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
  - 3.9.3.1. Retail Pharmacies and Drug Stores
  - 3.9.3.2. Clinics and Hospital Pharmacies
  - 3.9.3.3. Online Pharmacies
3.10. Market Attractiveness Analysis: Distribution Channel

4. Global Dermal Fillers Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Dermal Fillers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Product
- 5.3.3. By Ingredient
- 5.3.4. By Application
- 5.3.5. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 5.5.1. Absorbable
- 5.5.2. Non-Absorbable
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 5.6.1. Hyaluronic Acid
- 5.6.2. Poly-L-Lactic Acid
- 5.6.3. Calcium Hydroxylapatite
- 5.6.4. Polymethyl methacrylate
- 5.6.5. Collagen
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.7.1. Aesthetic Restoration
- 5.7.2. Dentistry
- 5.7.3. Reconstructive Surgery
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 5.8.1. Retail Pharmacies and Drug Stores
- 5.8.2. Clinics and Hospital Pharmacies
- 5.8.3. Online Pharmacies
5.9. Market Attractiveness Analysis

6. Europe Dermal Fillers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Product
- 6.3.3. By Ingredient
- 6.3.4. By Application
- 6.3.5. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 6.5.1. Absorbable
- 6.5.2. Non-Absorbable
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 6.6.1. Hyaluronic Acid
- 6.6.2. Poly-L-Lactic Acid
- 6.6.3. Calcium Hydroxylapatite
- 6.6.4. Polymethyl methacrylate
- 6.6.5. Collagen
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.7.1. Aesthetic Restoration
- 6.7.2. Dentistry
- 6.7.3. Reconstructive Surgery
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 6.8.1. Retail Pharmacies and Drug Stores
- 6.8.2. Clinics and Hospital Pharmacies
- 6.8.3. Online Pharmacies
6.9. Market Attractiveness Analysis

7. East Asia Dermal Fillers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Product
- 7.3.3. By Ingredient
- 7.3.4. By Application
- 7.3.5. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 7.5.1. Absorbable
- 7.5.2. Non-Absorbable
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 7.6.1. Hyaluronic Acid
- 7.6.2. Poly-L-Lactic Acid
- 7.6.3. Calcium Hydroxylapatite
- 7.6.4. Polymethyl methacrylate
- 7.6.5. Collagen
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.7.1. Aesthetic Restoration
- 7.7.2. Dentistry
- 7.7.3. Reconstructive Surgery
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 7.8.1. Retail Pharmacies and Drug Stores
- 7.8.2. Clinics and Hospital Pharmacies
- 7.8.3. Online Pharmacies
7.9. Market Attractiveness Analysis

8. South Asia & Oceania Dermal Fillers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Product
- 8.3.3. By Ingredient
- 8.3.4. By Application
- 8.3.5. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 8.5.1. Absorbable
- 8.5.2. Non-Absorbable
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 8.6.1. Hyaluronic Acid
- 8.6.2. Poly-L-Lactic Acid
- 8.6.3. Calcium Hydroxylapatite
- 8.6.4. Polymethyl methacrylate
- 8.6.5. Collagen
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.7.1. Aesthetic Restoration
- 8.7.2. Dentistry
- 8.7.3. Reconstructive Surgery
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 8.8.1. Retail Pharmacies and Drug Stores
- 8.8.2. Clinics and Hospital Pharmacies
- 8.8.3. Online Pharmacies
8.9. Market Attractiveness Analysis

9. Latin America Dermal Fillers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Product
- 9.3.3. By Ingredient
- 9.3.4. By Application
- 9.3.5. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 9.5.1. Absorbable
- 9.5.2. Non-Absorbable
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 9.6.1. Hyaluronic Acid
- 9.6.2. Poly-L-Lactic Acid
- 9.6.3. Calcium Hydroxylapatite
- 9.6.4. Polymethyl methacrylate
- 9.6.5. Collagen
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.7.1. Aesthetic Restoration
- 9.7.2. Dentistry
- 9.7.3. Reconstructive Surgery
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 9.8.1. Retail Pharmacies and Drug Stores
- 9.8.2. Clinics and Hospital Pharmacies
- 9.8.3. Online Pharmacies
9.9. Market Attractiveness Analysis

10. Middle East & Africa Dermal Fillers Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By Ingredient
- 10.3.4. By Application
- 10.3.5. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 10.5.1. Absorbable
- 10.5.2. Non-Absorbable
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2023 - 2030
- 10.6.1. Hyaluronic Acid
- 10.6.2. Poly-L-Lactic Acid
- 10.6.3. Calcium Hydroxylapatite
- 10.6.4. Polymethyl methacrylate
- 10.6.5. Collagen
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.7.1. Aesthetic Restoration
- 10.7.2. Dentistry
- 10.7.3. Reconstructive Surgery
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
- 10.8.1. Retail Pharmacies and Drug Stores
- 10.8.2. Clinics and Hospital Pharmacies
- 10.8.3. Online Pharmacies
10.9. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Dashboard
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Galderma Pharma S.A
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Sinclair Pharma plc
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Zimmer Biomet Holdings
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Allergan plc.
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Anika Therapeutics Inc.
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Merz Pharma GmbH & Co. KGaA
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Suneva Medical Inc.
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Teoxane Laboratories Inc.
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Prollenium Medical Technologies Inc.
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. Laboratoires Vivacy SAS
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. Fidia Pharma USA Inc.
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Product
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations